News, Analysis & Insights on Nutrition, Supplements, and Health
Special Edition: View from the aisles: The retailers' perspective
The actions of the New York Attorney General Eric Schneiderman have yet to filter down in a big way to the kind of questions retailers are getting from their customers on supplements. But business executives contacted by NutraIngredients-USA said that...
A recent study released by the AARP showed that brain health is becoming an increasing concern, and that more Americans are aware of the potential benefit that playing brain games and doing puzzles may have in combating cognitive decline. The results...
The Food and Drug Administration announced Wednesday that it has banned the use of the stimulant BMPEA in dietary supplements and foods. The agency also sent five warning letters to companies that have used the variant of amphetamine in weight loss...
The digital marketplace, participating in advocacy efforts, and why membership of a trade association is important: In this guest article, Daniel Fabricant, PhD, Executive Director and CEO, Natural Products Association gives his views on the retail...
Special Edition: View from the aisles: The retailers’ perspective
The first retailer standard for dietary supplements in the Global Retailer and Manufacturer Alliance (GRMA) should be available this year, giving retailers a single standard and auditing program to help reduce audits and costs while strengthening safety,...
An editorial in an academic journal has reignited the debate over the extent to which a poor diet – and the marketing tactics employed by the food industry – is responsible for America’s obesity epidemic.
Special Edition: View from the aisles: The retailers’ perspective
Ingredient suppliers can spend a lot of time and money differentiating their products but how do they communicate with the consumer, what issues are important to retailers, and is the investment worth it?
Organic and non-gmo trends
Congress needs to strengthen FDA’s oversight of genetically modified organisms before foreign countries, with potentially lower safety standards, begin genetically engineering crops used in finished products that are imported to the U.S., argues an...
Complying with FDA regulations can be a long and expensive process. Small wonder then that some companies choose not to, and instead deal in unapproved ingredients or products that contain them. With the FDA constrained to pursue only the most extreme...